Financial Ratios

MAKERS LABORATORIES LTD.

NSE : NABSE : 506919ISIN CODE : INE987A01010Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE136.15-1.75 (-1.27 %)
PREV CLOSE ( ) 137.90
OPEN PRICE ( ) 137.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4811
TODAY'S LOW / HIGH ( )132.55 142.00
52 WK LOW / HIGH ( ) 94157
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-10.780.35-3.29-0.254.98
   CEPS(Rs)-6.714.235.033.647.71
   DPS(Rs)0.000.000.000.001.00
   Book NAV/Share(Rs)98.78102.30100.9290.7484.81
   Tax Rate(%)6.1245.1522.06149.7218.81
Margin Ratios
   Core EBITDA Margin(%)-9.725.837.455.284.73
   EBIT Margin(%)-12.683.81-1.071.867.02
   Pre Tax Margin(%)-15.930.60-4.670.486.47
   PAT Margin (%)-14.950.33-3.64-0.245.25
   Cash Profit Margin (%)-9.313.975.813.638.48
Performance Ratios
   ROA(%)-7.470.21-2.11-0.184.32
   ROE(%)-11.720.34-3.43-0.296.24
   ROCE(%)-7.993.05-0.801.847.59
   Asset Turnover(x)0.500.640.580.770.82
   Sales/Fixed Asset(x)0.891.271.121.692.26
   Working Capital/Sales(x)-24.29-6.2720.8611.664.06
Efficiency Ratios
   Fixed Capital/Sales(x)1.130.790.900.590.44
   Receivable days55.2743.7060.5744.6463.54
   Inventory Days87.4480.4188.6579.2997.82
   Payable days60.1970.56115.9572.5570.74
Valuation Parameters
   PER(x)0.00522.610.000.0010.14
   PCE(x)-14.5443.1945.617.866.55
   Price/Book(x)0.991.782.370.330.62
   Yield(%)0.000.000.000.001.90
   EV/Net Sales(x)1.572.042.950.470.64
   EV/Core EBITDA(x)-22.2927.4035.198.296.29
   EV/EBIT(x)-12.3853.61-276.4725.569.17
   EV/CE(x)0.791.251.660.330.50
   M Cap / Sales1.351.712.650.290.56
Growth Ratio
   Net Sales Growth(%)-18.7717.93-13.5910.23-16.66
   Core EBITDA Growth(%)-176.824.7926.55-38.42-22.55
   EBIT Growth(%)-370.67520.68-149.68-70.86-28.76
   PAT Growth(%)-3802.50110.63-1205.82-105.06-19.89
   EPS Growth(%)-3185.43110.63-1205.82-105.06-19.89
Financial Stability Ratios
   Total Debt/Equity(x)0.160.340.280.240.15
   Current Ratio(x)0.920.721.101.232.02
   Quick Ratio(x)0.520.310.580.680.99
   Interest Cover(x)-3.911.19-0.301.3512.74
   Total Debt/Mcap(x)0.160.160.120.730.25

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.